ABOUT COMPANY
Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.
|
EARNINGS
Gross Profit (TTM): 2725000
Market Capitalization: 38526200
Operating Margin (TTM): -0.486
PE Ratio: None
PEG Ratio: -0.79
Profit Margin: -0.524
Revenue Per Share (TTM): 0.659
Revenue (TTM): 61763000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.046
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.346
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -32424822
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|